I'd like to send this to <a href=" http://www.sweetapple.co.uk/fda-nexium-warnings.pdf ">nexium injection package insert</a> Eliquis, the blood clot drug, eked out second-quarter global sales of $12 million, the company said on Thursday, following highly disappointing U.S. sales of $17 million in the first quarter. Investors have counted on the drug to be one of the company's biggest engines of sales growth.